Phathom Pharmaceuticals | 10-Q/A:季度报表(修正版)
Phathom Pharmaceuticals | 10-K/A:年度报表(修正版)
Phathom Pharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-James N. Topper(17.4%),Patrick J. Heron(17.3%)等
Phathom Pharmaceuticals | 4:持股变动声明-高管 Henderson Molly
Phathom Pharmaceuticals | 4:持股变动声明-高管 Nabulsi Azmi
Phathom Pharmaceuticals | 4:持股变动声明-董事 KARBE FRANK
Phathom Pharmaceuticals | 4:持股变动声明-董事 Topper James N
Phathom Pharmaceuticals | 4:持股变动声明-董事 Parikh Asit
Phathom Pharmaceuticals | 4:持股变动声明-董事 COLA MICHAEL F
Phathom Pharmaceuticals | 4:持股变动声明-董事 FIELDS HEIDI
Phathom Pharmaceuticals | 4:持股变动声明-董事 KARBE FRANK
Phathom Pharmaceuticals | 4:持股变动声明-董事 Stenhouse Mark
Phathom Pharmaceuticals | 4:持股变动声明-董事 Socks David A
Phathom Pharmaceuticals | 8-K:重大事件
Phathom Pharmaceuticals | 10-Q:季度报表
Phathom Pharmaceuticals | 8-K:Phathom Pharmicals公布2024年第一季度财务业绩并提供业务最新情况
Phathom Pharmaceuticals | DEF 14A:股东委托书决议
Phathom Pharmaceuticals | DEFA14A:其他
Phathom Pharmaceuticals | ARS:年度报告
Phathom Pharmaceuticals | 4:持股变动声明-高管 Henderson Molly
暂无数据